Dare Bioscience/ US23666P1012 /
| 2024-06-18 9:59:54 PM | Chg. -0.01 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 0.43USD | -2.49% | 9,708 Turnover: 4,182.53 |
-Bid Size: - | -Ask Size: - | 0.44 | 0.43 |
GlobeNewswire
05-14
Daré Bioscience Reports First Quarter 2024 Financial Results and Provides Company Update
GlobeNewswire
05-09
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
GlobeNewswire
05-07
Daré Bioscience to Host First Quarter 2024 Financial Results and Company Update Conference Call and ...
GlobeNewswire
05-02
Daré Bioscience Selected as a Member of ARPA-H Investor Catalyst Hub Spoke Network
GlobeNewswire
04-30
Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 F...
GlobeNewswire
04-30
XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfoli...
GlobeNewswire
04-23
Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contrace...
GlobeNewswire
04-11
Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...
GlobeNewswire
03-28
Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update
GlobeNewswire
03-21
Daré Bioscience to Host Full Year 2023 Financial Results and Company Update Conference Call and Webc...
GlobeNewswire
02-22
Daré Bioscience to Present at the International Society for the Study of Women’s Sexual Health (ISS...
GlobeNewswire
01-31
Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cre...
GlobeNewswire
01-04
Daré Bioscience’s DARE-LARC1 Platform Technology Achieves Proof-of-Concept Device that has Transfor...
GlobeNewswire
2023-12-20
Daré Bioscience Announces Positive Topline Pharmacokinetic and Exploratory Efficacy Results from th...
GlobeNewswire
2023-12-13
Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) Eunice K...
GlobeNewswire
2023-12-07
Daré Bioscience Announces FDA Clearance of Investigational New Drug (IND) Application for DARE-VVA1,...
GlobeNewswire
2023-12-04
Daré Bioscience Announces Commencement of Phase 3 Study of Ovaprene®, an Investigational Hormone-Fre...
GlobeNewswire
2023-11-20
Daré Bioscience and Premier Research Extend Strategic Partnership to Accelerate the Clinical Develop...
GlobeNewswire
2023-11-13
Daré Bioscience to Present at the Sexual Medicine Society of North America (SMSNA) 24th Annual Fall ...
GlobeNewswire
2023-11-09
Daré Bioscience Reports Third Quarter 2023 Financial Results and Provides Company Update
